Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

OrderlyMeds vs TOM Weight Loss

OrderlyMeds
Graded #78

Higher grade

vs+6.1000000000000085
TOM Weight Loss
Graded #193

Lower grade

The verdict

OrderlyMeds takes it — 72.4/100 to 66.3/100.

OrderlyMeds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. OrderlyMeds is a telehealth provider selling compounded semaglutide and tirzepatide with no membership fees or hidden costs.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueOrderlyMeds +34
92
58
Dose & formulationOrderlyMeds +2
64
62
Clinical oversightTOM Weight Loss +8
82
90
Labs & monitoringTOM Weight Loss +2
53
55
FulfillmentTOM Weight Loss +8
65
73
Contract termsEven
55
55
OrderlyMeds · left barTOM Weight Loss · right bar

The numbers

MetricOrderlyMedsTOM Weight Loss
WeighScore72.4/10066.3/100
GradeCC
Scorecard rank#78#193
Semaglutide$74/mo (starting dose, 2-mo starter plan, new patients only, compounded)$199/mo (all doses, compounded)
Tirzepatide$299/mo (compounded)$249/mo (all doses, compounded)
CoverageCoverage not published2 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
OrderlyMeds

Graded #78 · C

Strengths

  • The starter rate and the standing rate are both published, so the step-up is visible before signing up
  • No membership fees and no hidden costs, stated as such
  • The dose ladder is published: four weeks at 0.25 mg then four weeks at 0.5 mg
  • Brand-name routes are priced openly, at retail

Where it loses points

  • The $74 rate is a two-month starter plan billed as $149 up front, and it is open only to patients new to GLP-1 medication; the standing monthly rate is $149
  • Tirzepatide has no equivalent standing discount — $299/mo is the ongoing rate
  • Brand-name routes are priced at retail: Wegovy $1,839 and Zepbound $1,498
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
TOM Weight Loss

Graded #193 · C

Strengths

  • ABOM board-certified physician (Dr. Tran Le, NPI 1194212258, verified ACTIVE)
  • Solo-physician model — every patient sees Dr. Le directly
  • Flat-rate pricing — no dose escalation surcharge
  • LegitScript badge displayed
  • No FDA Warning Letters

Where it loses points

  • Limited geographic footprint — Texas and Utah only
  • No named compounding pharmacy partner disclosed
  • Compounded medications are not FDA-approved
  • Cash-pay only, no insurance

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard